BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 4137321)

  • 1. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR; Hall R
    Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves' disease.
    Endo K; Amir SM; Ingbar SH
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1113-23. PubMed ID: 6262364
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: The latest of L.A.T.S.
    Lancet; 1974 Aug; 2(7878):443-4. PubMed ID: 4136681
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
    Munro DS
    J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders.
    Sugenoya A; Kidd A; Row VV; Volpé R
    J Clin Endocrinol Metab; 1979 Mar; 48(3):398-402. PubMed ID: 218990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid stimulating immunoglobulin (TSI) in Graves' disease.
    Ochi Y; Inui T; Kouki T; Yamashiro K; Hachiya T; Kajita Y
    Endocr J; 1998 Dec; 45(6):701-8. PubMed ID: 10395224
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
    Bonnyns M; Vanhaelst L
    J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation of 125I-labeled receptor-purified Graves' immunoglobulins: properties of their binding to human thyroid membranes.
    Endo K; Borges M; Amir S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Sep; 55(3):566-76. PubMed ID: 6284786
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract]   [Full Text] [Related]  

  • 12. Humoral immunity in Graves' disease.
    McKenzie JM; Zakarija M; Sato A
    Clin Endocrinol Metab; 1978 Mar; 7(1):31-45. PubMed ID: 580600
    [No Abstract]   [Full Text] [Related]  

  • 13. Radio-receptor assay of TSH: its use to detect thyroid-stimulating immunoglobulins.
    Fenzi G; Macchia E; Bartalena L; Mazzanti F; Baschieri L; DeGroot LJ
    J Endocrinol Invest; 1978 Jan; 1(1):17-24. PubMed ID: 226573
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-tolerance and autoimmunity in the thyroid.
    Allison AC
    N Engl J Med; 1976 Oct; 295(15):821-7. PubMed ID: 183115
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
    Wong ET; Doe RP
    Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
    [No Abstract]   [Full Text] [Related]  

  • 18. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.